Manufacturer/Distributor:
Novartis Pharmaceuticals
www.novartis.ca
514-631-6775
Classification:
Synthetic analogue of somatostatin
Notice of Compliance (yyyy/mm/dd):
Date Marketed in Canada (yyyy/mm/dd):
Presentation:
Injection: 0.3 mg/mL. DIN: 02413299
Injection: 0.6 mg/mL. DIN: 02413302
Injection: 0.9 mg/mL. DIN: 02413310